Skip to main content

CuraGen Plans to Raise $75M in Private Placement

NEW YORK, Feb. 10 (GenomeWeb News) - CuraGen today said that it plans to raise $75 million in a private placement of convertible subordinated notes due in 2011.

CuraGen said it would grant the initial purchaser of the notes an option to purchase up to an additional $15 million aggregate principal amount of the notes.

The company said it plans to use a portion of the net proceeds to repay its existing debt, and the remainder for working capital, general corporate purposes, and possibly for future acquisitions of complementary businesses or technologies.

CuraGen has subordinated convertible debt of $150 million due in February of 2007. The company last week reported that it held cash and investments of $343.6 million as of Dec. 31, 2003.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.